Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 4/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17445953 | 0.94 | GLO1 (0.35) | PRKCAATMLMNAPOLBSMN1; SMN2 | |
| SCHEMBL17445964 | 0.87 | GLO1 (0.38) | ATMLMNAPOLBSMN1; SMN2TDP1 | |
| SCHEMBL12758189 | 0.81 | MAPT (0.48) | PRKCALMNAPOLBSMN1; SMN2TSHR | |
| SCHEMBL12260850 | 0.79 | PRKCA (0.36) | PRKCALMNATSHRALDH1A1 | |
| SCHEMBL17445963 | 0.77 | — | — | |
| SCHEMBL12758187 | 0.77 | LMNA (0.35) | PRKCALMNAPOLBSMN1; SMN2TSHR | |
| SCHEMBL17445954 | 0.72 | MAPT (0.55) | LMNAPOLBSMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL13398992 | 0.70 | — | — | |
| SCHEMBL14095017 | 0.68 | MEN1 (0.39) | POLBSMN1; SMN2TSHRL3MBTL1HPGD | |
| SCHEMBL17447694 | 0.68 | ALDH1A1 (0.39) | LMNASMN1; SMN2TSHRTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9518031-B2 | Photo-sensitive resin composition, cured film, method for forming a pixel, solid state image sensor, color filter and ultraviolet absorber | FUJIFILM CORPORATION (JP) | 2016-12-13 | — | — | US | disclosed |
| US-9481657-B2 | — | — | 2016-11-01 | — | — | US | disclosed |
| US-20160016919-A1 | PHOTO-SENSITIVE RESIN COMPOSITION, CURED FILM, METHOD FOR FORMING A PIXEL, SOLID STATE IMAGE SENSOR, COLOR FILTER AND ULTRAVIOLET ABSORBER | FUJIFILM CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160016919-A1 | PHOTO-SENSITIVE RESIN COMPOSITION, CURED FILM, METHOD FOR FORMING A PIXEL, SOLID STATE IMAGE SENSOR, COLOR FILTER AND ULTRAVIOLET ABSORBER | STRA6, TAS2R7, TAS1R3 | PRKCA 4559/4885ATM 2109/4885LMNA 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.